Building a Unified Data Foundation for AI and Healthcare Innovation with Chris Carmody

This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Chris Carmody, Chief Technology Officer, UPMC, who discusses using AI to turn growing volumes of healthcare data into actionable clinical insights, reduce fragmentation and create a more seamless experience across care settings.In collaboration with Philips.

In this episode, Dr. Patricia Henwood, EVP, Chief Clinical Officer at Jefferson Health, discusses the health system’s approach to AI integration, including its intent, integration, and impact framework, ambient AI results, and patient facing AI voice agents designed to improve care access, clinician efficiency, and patient experience.This episode is sponsored by Hippocratic AI.

Andy Colbert, Senior Managing Director at Ziegler, discusses the forces shaping ASC ownership and transactions in 2027, including joint ventures, private equity investment, and physician alignment. He also covers deal structure, succession planning, rising operating costs, and developing the next generation of physician leaders.This episode is sponsored by Ziegler.

In this episode, Jody Reyes, Chief Operating Officer of the Clinical Enterprise at UI Health Care, University of Iowa Health Care, joins the podcast to discuss the importance of accountability and ownership in healthcare leadership. She also shares insights on navigating the changing economics of healthcare and adapting operational strategies to meet evolving organizational challenges.

This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Deb Anderson, MBA, Chief Information Officer, Endeavor Health, discussing the integration of three electronic health records into one system, technology simplification, and strategies for managing costs while advancing digital transformation.

In this episode, Jennifer Jasmine Arfaa, PhD, CPXP, Senior Vice President, Chief Patient Experience Officer, Westchester Medical Center Health Network, discusses improving patient experience by connecting quality, safety, employee engagement, and patient feedback.

In this episode, Matt Hare, Vice President of Network Growth and Client Success, CoverMyMeds, and Bill Sicheneder, Vice President of Network Sales, CoverMyMeds, discuss how healthcare organizations can reduce medication access barriers through stronger connectivity, streamlined workflows, and strategic partnerships. They also explore preparing for benefits reverification season and building scalable systems that improve efficiency and patient access.This episode is sponsored by CoverMyMeds.

In this episode, Bahar Bazmi, Chief Revenue Cycle Officer at WVU Health System, joins the podcast to discuss the revenue cycle through the lens of the “sandwich analogy” and how its different components work together to support financial performance. She also shares insights on defining success over the next year and empowering staff to strengthen revenue cycle operations.

This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Tinu Tadese, MD, System Chief Medical Informatics Officer, Boston Medical Center, who discusses reducing data fragmentation, preserving clinical context across care transitions and turning patient data into actionable insightsIn collaboration with Philips.

In this episode, John D’Angelo, MD, President and CEO of Northwell Health, discusses a fundamentally different approach to treating rheumatoid arthritis (RA): bioelectronic medicine, which uses the body’s own nervous system to help regulate the inflammation that drives the disease. Delivered by a small implanted medical device that stimulates the vagus nerve, the FDA-approved therapy offers an alternative to costly medications that can also cause significant side effects or fail to provide adequate relief.Northwell Health was the first health system to build a clinical program around the therapy, which builds on decades of pioneering research at its Feinstein Institutes. Dr. D’Angelo discusses what this new therapeutic category could mean for people living with RA and, more broadly, the future of autoimmune care.